A Randomized, Double-Blind, Single Center, Efficacy and Safety Study of Allogeneic HB-adMSCs Against COVID-19.
Clinical trial NCT04348435 · COMPLETED
Trial details
- NCT number
- NCT04348435
- Sponsor
- Hope Biosciences Research Foundation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-14
- Primary completion
- 2021-05-12
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.